These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21962064)

  • 21. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The independent effects of hypovolaemia and pulmonary vasoconstriction on ventricular function and exercise capacity during acclimatisation to 3800 m.
    Stembridge M; Ainslie PN; Boulet LM; Anholm J; Subedi P; Tymko MM; Willie CK; Cooper SM; Shave R
    J Physiol; 2019 Feb; 597(4):1059-1072. PubMed ID: 29808473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphodiesterase type 5 inhibition improves arterial stiffness after exercise but not exercise capacity in hypertensive men.
    Attinà TM; Drummond ID; Malatino LS; Maxwell SR; Webb DJ
    Am J Hypertens; 2013 Mar; 26(3):342-50. PubMed ID: 23382484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sildenafil and bosentan improve arterial oxygenation during acute hypoxic exercise: a controlled laboratory trial.
    Olfert IM; Loeckinger A; Treml B; Faulhaber M; Flatz M; Burtscher M; Truebsbach S; Kleinsasser A
    Wilderness Environ Med; 2011 Sep; 22(3):211-21. PubMed ID: 21723164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise endurance in chronic obstructive pulmonary disease patients at an altitude of 2640 meters breathing air and oxygen (FIO2 28% and 35%): a randomized crossover trial.
    Maldonado D; González-García M; Barrero M; Jaramillo C; Casas A
    COPD; 2014 Aug; 11(4):401-6. PubMed ID: 24111929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of theophylline and endothelin receptor antagonism improves exercise performance of rats under simulated high altitude.
    Radiloff DR; Zhao Y; Boico A; Wu C; Shan S; Palmer G; Hamilton K; Irwin D; Hanna G; Piantadosi CA; Schroeder T
    J Appl Physiol (1985); 2012 Oct; 113(8):1243-52. PubMed ID: 22898548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seven intermittent exposures to altitude improves exercise performance at 4300 m.
    Beidleman BA; Muza SR; Fulco CS; Cymerman A; Sawka MN; Lewis SF; Skrinar GS
    Med Sci Sports Exerc; 2008 Jan; 40(1):141-8. PubMed ID: 18091011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity.
    Rietema H; Holverda S; Bogaard HJ; Marcus JT; Smit HJ; Westerhof N; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Eur Respir J; 2008 Apr; 31(4):759-64. PubMed ID: 18094009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of a single dose of phosphodiesterase type 5 inhibitor (sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients.
    Guimaraes GV; d'Avila VM; Pires P; Bacal F; Stolf N; Bocchi E
    Transplant Proc; 2007 Dec; 39(10):3142-9. PubMed ID: 18089340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.
    Richalet JP; Gratadour P; Robach P; Pham I; Déchaux M; Joncquiert-Latarjet A; Mollard P; Brugniaux J; Cornolo J
    Am J Respir Crit Care Med; 2005 Feb; 171(3):275-81. PubMed ID: 15516532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
    N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sildenafil improves exercise hemodynamics in Fontan patients.
    Van De Bruaene A; La Gerche A; Claessen G; De Meester P; Devroe S; Gillijns H; Bogaert J; Claus P; Heidbuchel H; Gewillig M; Budts W
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):265-73. PubMed ID: 24478333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of caffeine on submaximal exercise performance at altitude.
    Fulco CS; Rock PB; Trad LA; Rose MS; Forte VA; Young PM; Cymerman A
    Aviat Space Environ Med; 1994 Jun; 65(6):539-45. PubMed ID: 8074628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes.
    Faoro V; Huez S; Giltaire S; Pavelescu A; van Osta A; Moraine JJ; Guenard H; Martinot JB; Naeije R
    J Appl Physiol (1985); 2007 Oct; 103(4):1161-5. PubMed ID: 17615281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of sildenafil on heart rate variability in healthy subjects.
    Siepmann M; Rauh R; Dill O; Agelink MW; Mueck-Weymann M
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):598-600. PubMed ID: 18030072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.
    Zhang ZN; Jiang X; Zhang R; Li XL; Wu BX; Zhao QH; Wang Y; Dai LZ; Pan L; Gomberg-Maitland M; Jing ZC
    Heart; 2011 Nov; 97(22):1876-81. PubMed ID: 21948962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial.
    Bates MG; Thompson AA; Baillie JK; Sutherland AI; Irving JB; Hirani N; Webb DJ
    High Alt Med Biol; 2011; 12(3):207-14. PubMed ID: 21962063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.